Skip to content
Home/Companies/Healthcare/GTP Bioways

GTP Bioways

Healthcare·France·Exited 2024·Held 5yr
Entry
2019
Hold
5yr
Exit
2024

Who owns GTP Bioways?

GTP Bioways was owned by Merieux Equity Partners through Mérieux Participations 3 (2019 vintage) from 2019 to 2024, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Merieux Equity Partners
Investor
Merieux Equity Partners
Mérieux Participations 3 · 2019 · Buyout

Key facts

HQFrance
SectorHealthcare
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2024

More from Mérieux Participations 3

Other portfolio companies in the same fund.

Ceva Sante Animale
Ceva Sante Animale
Active
HealthcareFrance
Janvier Labs
Janvier Labs
Active
HealthcareFrance· 2022
Dental Monitoring
Dental Monitoring
Active
HealthTechFrance· 2021
Domus VI
Domus VI
Active
HealthcareFrance· 2021
DomusVi
DomusVi
Active
HealthcareFrance· 2021
SERB Pharmaceuticals
SERB Pharmaceuticals
Active
HealthcareBelgium· 2021

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track GTP Bioways

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy GTP Bioways?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on GTP Bioways.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue